Скачать или смотреть GenScript’s cutting-edge Technologies for Bispecific Development

This talk, “Seamless Concept to Candidate: GenScript’s cutting-edge Technologies for Bispecific Development” was given during the 2024 PEGS Europe conference in Barcelona, Spain by Amanda Grimm, senior marketing manager for GenScript's antibody drug discovery portfolio.

Bispecific antibody drug development is a complex process requiring careful consideration of target biology, mechanism of action, antibody format, and other critical factors. Leveraging advanced technologies and strategic planning can help navigate these challenges and lead to successful therapeutic outcomes. Join Amanda as she discusses GenScript’s integrated technologies that will support your bispecific design, expression, and assess your developability.